|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
Global Market Report of Annamycin (CAS 92689-49-1) December 2024 CAS 92689-49-1 Annamycin Chemical Report & Database ... Report & Database definitions: Name: Annamycin: Annamycin; (7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-Dihydroxy-3-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy ... APPLICATIONS: Chemical or Reaction Intermediate The Annamycin Report & Database gives Market Consumption ... Callisto Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Phase I clinical trials in patients with RA. L-Annamycin The company has a license agreement ... and commercially exploit the L-Annamycin patent rights. L-Annamycin, an anthracycline drug for leukemia ... Cancer Therapies: Market Research Report This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. The report provides separate comprehensive analytics for the US, Japan, ... Acute Myeloid Leukemia (AML) Therapeutics: Market Research Report This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the ... Acute Myeloid Leukemia - Pipeline Review, 2019 ... Daunorubicin Crenolanib AB8939 Sapacitabine Liposomal Annamycin MGD006 SEL 120 APVO436 Pevonedistat ... Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Osteosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteosarcoma - Drugs In Development, 2022, provides an ... Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Nerve ... Soft Tissue Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major soft tissue neoplasms markets are expected to exhibit a CAGR of 6.07% during 2024-2034. The soft tissue neoplasms market has been comprehensively analyzed in IMARC's new report titled "Soft Tissue Neoplasms Market: Epidemiology, Industry Trends ... |